Neuromuscular blocking agent. Concomitant use with deflazacort may increase risk of developing acute myopathy.
Source: NLP:deflazacort
6 interactions on record
Neuromuscular blocking agent. Concomitant use with deflazacort may increase risk of developing acute myopathy.
Source: NLP:deflazacort
Pancuronium and vecuronium may manifest additive neuromuscular blocking effects when used together due to similar mechanism of action.
Source: NLP:vecuronium bromide
Desflurane reduces ED95 of pancuronium by approximately 50%. Dose adjustment may be needed during maintenance anesthesia.
Source: NLP:desflurane
Isoflurane potentiates the muscle relaxant effect of pancuronium, reducing required ED95 by approximately 25-40%. Dose adjustment required.
Source: NLP:isoflurane
Sevoflurane increases both the intensity and duration of neuromuscular blockade induced by pancuronium. Dosage adjustments required.
Source: NLP:sevoflurane
May increase serum concentration of trospium and/or pancuronium due to competition for renal tubular secretion. Careful patient monitoring is recommended.
Source: NLP:trospium chloride